Oramed Pharmaceuticals In... (ORMP)
NASDAQ: ORMP
· Real-Time Price · USD
2.08
-0.04 (-1.89%)
At close: Aug 15, 2025, 3:59 PM
2.07
-0.48%
After-hours: Aug 15, 2025, 05:49 PM EDT
Oramed Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 |
Net Income | 4.39M | 20.75M | 10.23M | 5.09M | -16.94M | -20.91M | -30.67M | -37.76M | -37.13M | -37.06M | -31.62M | -25.52M | -22.99M | -18.8M | -15.46M |
Depreciation & Amortization | 215K | 217K | 215K | 196K | 160K | 121K | 84K | 58K | 53K | 57K | 70K | 87K | 77K | 60K | 35K |
Stock-Based Compensation | 4.19M | 4.74M | 5.33M | 4.21M | 5.39M | 7.59M | 7.65M | 11.51M | 10.67M | 8.61M | 7.71M | 4.09M | 2.69M | 2M | 1.33M |
Other Working Capital | 261K | 270K | 282K | -471K | -2.15M | -522K | -319K | -567K | -337K | -2.88M | -4.16M | -2.87M | -3.38M | -3.36M | -2.88M |
Other Non-Cash Items | -19.45M | -30.14M | -22.03M | -19.63M | -4.28M | -4.64M | -1.76M | -778K | -671K | -244K | -390K | 395K | 351K | 1.08M | 837K |
Deferred Income Tax | n/a | -2.61M | -77K | -77K | -77K | 2.53M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 242K |
Change in Working Capital | 2.73M | 2.92M | -2.51M | -2.7M | -3.8M | -3.17M | 353K | -943K | 314K | -2.02M | -3.58M | -985K | -1.31M | -1.84M | -2.2M |
Operating Cash Flow | -7.92M | -1.51M | -6.22M | -10.29M | -16.94M | -18.49M | -24.34M | -27.92M | -26.76M | -30.66M | -27.81M | -21.93M | -21.18M | -17.5M | -15.22M |
Capital Expenditures | -10K | -37K | -57K | -254K | -559K | -648K | -648K | -496K | -188K | -94K | -76K | -62K | -375K | -427K | -425K |
Cash Acquisitions | n/a | 75.09M | 75.09M | 69.09M | 69.09M | -6M | -6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -43.76M | -105M | -175.92M | -190.92M | -231.12M | -137.32M | -173.41M | -154.41M | -214.2M | -238.8M | -144.42M | -144.7M | -53.82M | -44.78M | -38.59M |
Sales Maturities Of Investments | 76.52M | 184.56M | 146.14M | 118.14M | 139.88M | 122.52M | 183.68M | 185.09M | 134.29M | 128.52M | 31.15M | 20.75M | 30.43M | 61.46M | 34.63M |
Other Investing Acitivies | 87.64M | n/a | n/a | 6M | 6.02M | 6.02M | 6.02M | 26K | 2K | -1K | -2K | -1K | -1K | -1K | -4K |
Investing Cash Flow | 120.39M | 79.53M | -29.84M | -73.04M | -91.78M | -15.42M | 9.65M | 30.21M | -80.1M | -110.37M | -113.34M | -124.01M | -23.76M | 16.25M | -4.38M |
Debt Repayment | -73.53M | -73.53M | -43.39M | -24.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -1.29M | -2K | -2K | -2K | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1.02M | 73.53M | 73.94M | 73.94M | 74.57M | -44K | -44K | -721K | -118K | 16.11M | 19.11M | 23.53M | 22.91M | 6.74M | 3.75M |
Financial Cash Flow | -75.84M | -2K | 50.36M | 71.79M | 100.97M | 30.73M | 10.92M | 10.78M | 67.17M | 117.88M | 139.73M | 162.87M | 102.89M | 49.35M | 47.47M |
Net Cash Flow | 36.64M | 77.99M | -5.53M | -31.41M | -27.73M | -23.13M | -3.86M | 13.01M | -39.63M | -23.1M | -1.41M | 16.95M | 57.95M | 48.1M | 27.87M |
Free Cash Flow | -7.93M | -1.55M | -6.28M | -10.55M | -17.5M | -19.13M | -24.99M | -28.41M | -26.95M | -30.75M | -27.88M | -21.99M | -21.56M | -17.92M | -15.64M |